When the U.S. Department of Justice moved to reclassify medical marijuana to a Schedule III drug on April 23, 2026, it set the stage for a vast amount of medical research that has been hobbled for decades by its more restrictive Schedule I classification.

The DOJ is loosening federal regulations on medicinal marijuana, moving it from Schedule I to Schedule III, allowing tax breaks and more research.

A federal order by the Department of Justice to reclassify state-legal medical marijuana as a less dangerous drug brings possibilities for the substance to be studied by

What GOP Sen. Tom Davis said on the Senate floor Wednesday sounded almost surreal in the Republican-supermajority chamber.

There are questions about the future of marijuana laws in Indiana after the federal government moved to reclassify the drug. On Tuesday, Gov. Mike Braun was asked where Indiana stands as that shift

The Drug Enforcement Administration (DEA) has announced that it will begin accepting applications this week for medical marijuana businesses to apply for federal protections being granted under the Trump administration’s cannabis rescheduling process.

The DEA announced the new requirements for medical marijuana dispensaries seeking federal compliance, including application details and costs.